Skip to main content
. 2019 Jun 13;11(7):e10292. doi: 10.15252/emmm.201910292

Figure EV3. Patient‐derived xenografts become resistant to PI3Ki.

Figure EV3

  • A
    Longitudinal tumor growth follow‐up in ETP‐47037 or vehicle‐treated mice injected with patient‐derived h676 GSCs. Data are representative of n = 4 independent tumors.
  • B
    Longitudinal tumor growth follow‐up in ETP‐47037 or vehicle‐treated mice injected with patient derived h543 GSCs. Data are representative of n = 4 independent tumors.
  • C
    Western blot images (left) and p‐AKT/AKT or pS6/S6 protein levels (right) in vehicle‐ or ETP‐47037‐treated tumors. Data are representative of n = 4 independent tumors.
  • D
    TRF1 nuclear fluorescence in ETP‐47037 or vehicle‐treated tumors. Scale bars, 10 μm. Data are representative of n = 4 independent tumors
  • E
    Western blot images (left) and TRF1 protein levels (right) in vehicle‐ or ETP‐47037‐treated tumors. Data are representative of n = 4 independent tumors.
Data information: Data are represented as mean ± SEM.Source data are available online for this figure.